Cytocraft Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Cytocraft Bio General Information

Description

Provider of cell therapy technologies designed for research, service, production and sales in the biotechnology sector. The company specializes in the development, medical transformation and clinical application of cell therapy technologies, and integrates cell storage, cell preparation, cell quality inspection, medical transformation, reagent production and a nationwide sales network, enabling healthcare professionals and researchers to leverage advanced cell therapies for improved patient outcomes.

Contact Information

Website
www.cytocraft.cn
Formerly Known As
Cytocraft Biotechnology Development Co., Ltd., Cytocraft Biotechnology Development
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 1, 19th Floor, Building 7
  • No. 1333, Tianlong Avenue, Jinniu High-tech Industrial Park
  • Chengdu, Sichuan
  • China
+86 400
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • No. 1, 19th Floor, Building 7
  • No. 1333, Tianlong Avenue, Jinniu High-tech Industrial Park
  • Chengdu, Sichuan
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytocraft Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 04-Jul-2023 Completed Generating Revenue
To view Cytocraft Bio’s complete valuation and funding history, request access »

Cytocraft Bio Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cytocraft Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210238549-A1 Use of memory lymphocyte population in liver cancer treatment Inactive 24-Jan-2019
US-20250361484-A1 Use of memory lymphocyte population in liver cancer treatment Pending 24-Jan-2019

Cytocraft Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nanjing Jinguang Zijin Venture Capital Management Venture Capital Minority
Oriental Fortune Capital Venture Capital Minority
To view Cytocraft Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Cytocraft Bio FAQs

  • When was Cytocraft Bio founded?

    Cytocraft Bio was founded in 2017.

  • Where is Cytocraft Bio headquartered?

    Cytocraft Bio is headquartered in Chengdu, China.

  • What industry is Cytocraft Bio in?

    Cytocraft Bio’s primary industry is Biotechnology.

  • Is Cytocraft Bio a private or public company?

    Cytocraft Bio is a Private company.

  • What is Cytocraft Bio’s current revenue?

    The current revenue for Cytocraft Bio is .

  • Who are Cytocraft Bio’s investors?

    Nanjing Jinguang Zijin Venture Capital Management and Oriental Fortune Capital have invested in Cytocraft Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process